PMEF
KRON

Point72 Middle East FZE’s Kronos Bio KRON Stock Holding History

Point72 Middle East FZE’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,086
Closed -$12.2K – 1675
2023
Q2 		$12.2K Buy
+7,086
New +$11.3K ﹤0.01% 1405
2023
Q1 		– Sell
-2,152
Closed -$3.49K – 1933
2022
Q4 		$3.49K Buy
+2,152
New +$4.95K ﹤0.01% 1798

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Middle East FZE's KRON Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Kronos Bio (KRON) in Q3 2023, closing a stake of 7,086 shares — an estimated $12.2K sold.

Point72 Middle East FZE first reported a position in KRON in Q4 2022 and held it in 2 quarters. The position peaked at $12.2K in Q2 2023. 63 funds tracked by Wall St. Rank hold KRON as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Kronos Bio position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 7,086 Kronos Bio shares in Q3 2023, an estimated $12.2K.
  • Point72 Middle East FZE first reported a position in Kronos Bio in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Kronos Bio position peaked at $12.2K in Q2 2023.
  • 63 funds tracked by Wall St. Rank held Kronos Bio as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.